Fetuin A Association in Periodontal Disease and Diabetes Mellitus
NCT ID: NCT06064786
Last Updated: 2023-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
45 participants
OBSERVATIONAL
2023-08-01
2023-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methodology: Forty-five periodontitis stage III patients categorized into 3 groups according to whether having type II diabetes mellitus or not were compared to systemically and periodontally healthy participants in this investigation. Clinical parameters for all groups were recorded. Assessment of GCF levels of fetuin A and hs-CRP were done to all enrolled participants utilizing an enzyme linked immune-sorbent assay (ELISA) kit. Receiver operating characteristic (ROC) curve was performed to reveal sensitivity, specificity, predictive value and diagnostic accuracy of the markers used.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serum Hs-CRP in Periodontitis Patients With or Without Diabetes
NCT03908606
Saliva Levels of S100A12, CRP, Fetuin-A in Periodontal Disease Patients
NCT03345745
Effect of Periodontal Treatment on Visfatin, fetuin-a and Sirtuin 1 of Patients With Periodontitis and Type 2 Diabetes
NCT05662475
Serum Ferritin and Hepicidin Concentration in Chronic Periodontitis Patients With T2DM
NCT03964428
Evaluation and Correlation of Serum Fetuin-A Levels in Periodontal Health and Disease: A Clinico-biochemical Study
NCT04198610
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
15 healthy patients with generalized periodontitis stage III.
GCF levels of fetuin A and hsCRP evaluation
ELIZA kits are used for GCF levels of fetuin A and hsCRP evaluation
Group II
15 patients suffering from type 2 diabetes mellitus with generalized periodontitis stage III
GCF levels of fetuin A and hsCRP evaluation
ELIZA kits are used for GCF levels of fetuin A and hsCRP evaluation
Group III
15 systemically healthy patients without periodontitis
GCF levels of fetuin A and hsCRP evaluation
ELIZA kits are used for GCF levels of fetuin A and hsCRP evaluation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GCF levels of fetuin A and hsCRP evaluation
ELIZA kits are used for GCF levels of fetuin A and hsCRP evaluation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Systemic diseases (except DM in group B),
3. Periodontitis patients having periodontal treatment recently (past 6 months),
4. Pregnancy, lactation, contraceptive pills,
5. Anti-inflammatory/ immunosuppressive drugs.
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fayoum University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nayroz Tarrad
associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
faculty of dentistry, Fayoum university
Al Fayyum, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC-FDBSU/03082023-2/ER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.